Of a series of IOO consecutive patients undergoing closed mitral valvotomy, 84 were in atrial fibrillation after operation. Fifty-six were treated by DC countershock; 7 returned to sinus rhythm without defibrillation, and in the remaining 2I defibrillation was not attempted. Of those patientsfibrillatingfor more than a year, none remained in sinus rhythm one year after defibrillation, and no patient remained in sinus rhythm for more than 5 weeks when atrialfibrillation had been present for 5 years before operation. A small proportion ofpatients in whom fibrillation had been present for less than a year, or had appeared after operation, maintained sinus rhythm for I to 2 years or more: approximately one-third at i year, and one-quarter at 2 years. Threequarters of those patients in sinus rhythm before and after operation remained in sinus rhythm for 3 years. A large heart, low amplitude f waves, and male sex were also unfavourable features.
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It is suggested that the development of atrial fibrillation is an event in the natural history of mitral stenosis which depends relatively little on the degree of stenosis or its relief by operation. Though fibrillation is sometimes precipitated by operation, defibrillation postoperatively is only rarely followed by the maintenance of sinus rhythm for more than i to 2 years. The attempt to restore sinus rhythm is only worth while when atrial fibrillation has been present for less than I year.
The advantages of sinus rhythm over atrial fibrillation in chronic rheumatic heart disease are generally agreed. The incidence of arterial embolus is higher in atrial fibrillation than in sinus rhythm (Goldman, I960; Szekely, I964) ; haemodynamic improvement after reversion to sinus rhythm has been shown both in the quinidine era and since the advent of direct-current countershock (Kahn et al., I964; Graettinger, Carleton, and Muenster, I964; Morris et al., I965; Benchimol, Lowe, and Akre, I965;  Killip and Baer, I966; Resnekov, I967) . Subjectively, awareness of the heart beat, and particularly of rapid irregular palpitation, is less when the rhythm is of sinus origin. When quinidine was the accepted method of treatment for achieving reversion to sinus rhythm, it was only used in a small proportion of cases; large doses were often required and these commonly caused unpleasant side effects, with a real risk of sudden death. The drug was therefore used only where the likelihood of success was thought to be high. After the introduction of mitral valvotomy, it was recognized that patients who had had a successful operation constituted a relatively favourable group in this respect; in selected cases, reversion to sinus rhythm was achieved in 70 per cent or more of cases. A high relapse rate was reported by Bloom (I963) who found that few patients successfully converted to sinus rhythm with quinidine after valvotomy remained in normal rhythm for long, particularly when atrial fibrillation was present before operation.
The introduction of DC countershock (Lown, Amarasingham, and Neuman, I962) provided a safe, simple, and effective method of restoring sinus rhythm. This was achieved in over 75 per cent of cases after mitral valvotomy (Oram and (1970) found that quinidine prophylaxis, using a slow-release preparation, was effective and safe.
Analysis of results Successful defibrillation
was defined as the restoration of a sinus mechanism for even a few beats; a few patients showed a junctional rhythm immediately after defibrillation, but soon afterwards reverted to a sinus mechanism. The patients were examined at regular intervals and electrocardiograms recorded; 4 patients living overseas were not seen, but reports were obtained from their physicians. A few patients, returning to atrial fibrillation, were defibrillated a second or a third time and are discussed below. The duration of sinus rhythm after electroconversion was examined in relation to the age and sex of the patient, the duration of atrial fibrillation, the size of the heart (cardiothoracic ratio), the magnitude of f waves in lead Vi, the operative results, and the adequacy of maintenance therapy with quinidine or procainamide. (Table 4) The longer atrial fibrillation had been present before valvotomy, the lower was the immediate success rate for electrical defibrillation, and the fewer the patients remaining in sinus rhythm after any specified period of followup. Thus, no patient remained in sinus rhythm for more than a year who had been fibrillating for more than a year before operation. Defibrillation was immediately successful in only 50 per cent of 24 patients whose arrhythmia had been present for more than 5 years; atrial fibrillation returned within only expected that sinus rhythm will be maintained for long even if successfully restored after valvotomy. Furthermore, if atrial fibrillation is already present before operation, the maintenance of sinus rhythm postoperatively will depend on the state of the sinus node and atrial myocardium, and be influenced only marginally by the successful surgical relief of mitral stenosis. Conversely, those patients with relatively undamaged node and atrial wall are much less likely to develop atrial fibrillation at or immediately after mitral valvotomy, and may well remain in sinus rhythm for several years after operation. This hypothesis accords well with our observations, and does not encourage an attempt to find more effective antiarrhythmic drugs in this situation. Though the prophylactic use of quinidine may be valuable in paroxysmal atrial fibrillation, its value in preventing the return of atrial fibrillation after defibrillation is disputed. Though Hartel et al. (I970) showed that quinidine delayed the return of atrial fibrillation, their period of follow-up extended for 3 months only. It seems unlikely that quinidine or any other drug will be effective in increasing the duration of maintained sinus rhythm for more than a few weeks or months.
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